BioVex Said to Snag Another $30 Million
New York Times - Tue Nov 10, 6:56 am ETBioVex , a Woburn, Mass.-based biotechnology company that raised $40 million in venture capital in March to develop a novel cancer-fighting treatment, plans to announce Tuesday that it has raised another $30 million, The Boston Globe reported.






